Citizens raises Progyny price target to $33 from $31
Citizens,, maintained Progyny’s Market Outperform rating and raised its price target to $33.00 per share from $31.00.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.